disease

(redirected from Neglected disease)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
References in periodicals archive ?
DNDi and the WHO have compiled a list of 18 officially neglected diseases, which includes such horrors as sleeping sickness, river blindness and paediatric HIV.
6 new drug products--including new molecular entities, vaccines, indications, combinations and formulations --were approved each year to combat neglected diseases.
Elimination of neglected diseases and other poverty-related infections.
A recently released report by the Center for Global Health R&D Policy Assessment examines the merits of tax credits for global health, drawing from HR 3156, a proposal for a 50% non-clinical neglected diseases research tax credit, which was referred to the House Ways and Means Committee in 2009.
Bureaucracy and financial commitment from governments and funding organizations are a growing concern for those involved in neglected disease partnerships.
Scientists are aware of molecules that could potentially treat neglected diseases, but they have been mostly unable to make a business case for spending millions of dollars testing those molecules," Ridley explains.
Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases, Michael Kremer and Rachel Glennerster (Princeton: Princeton University Press, 2004), x52 pp.
The Bill and Melinda Gates Foundation has become a major force in neglected disease drug development.
The new report, Biotechnology: Bringing Innovation to Neglected Disease Research and Development, finds that 64% of all products in development by biotechnology companies across the pipeline of drugs, vaccines, and diagnostics for neglected diseases involve partnering.
Through its Humanitarian Assistance for Neglected Diseases initiative, Genzyme is participating in efforts to discover and advance novel treatments for neglected diseases affecting the developing world.
Stinchcomb continued, "BVGH's efforts to improve access to funding and market information should encourage more biotechnology companies to join in the development of therapeutics, vaccines and diagnostics for these and other neglected diseases.
The analysis shows that 134 biotechnology companies are participating in neglected disease research and development, which represents participation in 39% of the 191 new drugs, vaccines and diagnostics in development for neglected diseases such as malaria, tuberculosis and dengue fever.